I wonder if you could give me your thoughts on the weight loss field and a bit of an overview of what's available, what's working, what isn't, and how you see that evolving, including what you're working on.

Sure.

I think if we accept Zepoundil to Zepatitis Twin Creighton Standard of Care, that it's it's important to acknowledge that the rise of GLP-1 drugs and GLP-GYPS has really transformed the treatment of obesity and overweight.

It's made a huge difference.

But I still see this really as the first flush of treatments.

There was an observation that in creating drugs given to patients with type 2 diabetes happened to be losing weight and move on a decade later, et cetera, we've developed this incredible field where the same modality is being used to suppress appetite.

So this is the first flagpole in the ground saying, yeah, the industry can develop drugs that seriously affect weight.

Do you see this as being something that is used in combination with other treatments? You mentioned it potentially being that.